ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,427.13
      -2.31%
      US Tech 100
      18,596.00
      -3.27%
      Dow Jones
      39,853.87
      -1.25%
      Brent Oil
      80.73
      -0.06%
      Bitcoin
      65,626.28
      -0.45%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Corcept Therapeutics Inc (CORT)

      7. Corcept Therapeutics Inc (CORT) Financials

      Corcept Therapeutics Inc

      Corcept Therapeutics Inc (CORT)

      NASDAQ
      34.48
      -0.08
      (-0.23%)
      At close: July 24 4:00PM
      Delayed by 15 minutes
      34.48
      -0.01
      ( -0.03% )
      After Hours: 4:15PM
      Delayed by 15 minutes

      Corcept Therapeutics Inc Financial Summary

      The current CORT market cap is 3.59B. The company's latest EPS is USD 1.0195 and P/E is 33.83.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 105.65M117.72M123.6M135.41M146.81M
      Operating Income 14.85M29.58M31.18M31.67M29.5M
      Net Income 15.88M27.53M31.38M31.36M27.76M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 306.49M353.87M365.98M401.86M482.38M
      Operating Income 111.61M128.2M124.48M98.63M107.28M
      Net Income 94.18M106.01M112.51M101.42M106.14M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 617.85M524.63M594.02M621.52M655.94M
      Total Liabilities 88.26M103.01M132.34M114.81M108.07M
      Total Equity 529.58M421.61M461.68M506.71M547.86M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 412.31M571.73M423.76M583.43M621.52M
      Total Liabilities 41.13M48.39M47.95M81.59M114.81M
      Total Equity 371.18M523.34M375.81M501.84M506.71M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 25.96M68.24M121.15M127.04M23.76M
      Investing 207.48M183.38M73.81M90.91M-9.01M
      Financing 181k-145.57M-149.49M-148.72M-543k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 136.12M151.97M167.89M120.32M127.04M
      Investing -117.83M-119.26M136.13M-114.33M90.91M
      Financing -28.65M12.21M-302.59M-17.28M-148.72M

      Stats and Ratios

      Market Cap 3.59B
      Price to Earnings Ratio 33.83
      Price to Sales Ratio 7.44
      Price to Cash Ratio 26.49
      Price to Book Ratio 7.09
      Dividend Yield -

      Share Statistics

      Shares Outstanding 104.11M
      Average Volume (1 week) 876.51k
      Average Volume (1 Month) 815.62k
      52 Week Change 44.63%
      52 Week High 35.22
      52 Week Low 20.84
      Spread (Intraday) 4.32 (12.16%)

      Company Info

      Company Name Corcept Therapeutics Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.corcept.com
      Industry pharmaceutical preparations (2834)